Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
Login Archives Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
JAZZ

Jazz Pharma Plc

Cannabis

The Medical Marijuana Stock to Buy Before the Schedule I Change

March 24, 2021 by Money Morning Staff Reports

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The FDA's Schedule I label on cannabis is the single biggest barrier holding medical marijuana stocks back.

That barrier could be coming down soon, and you'll want to own shares of GW Pharmaceuticals when it does.

Lo and behold – a bill is moving through the U.S.

Senate to do just this.

Here's why this bill could be the biggest breakthrough for medical marijuana stocks we've ever seen...

Cannabis

There's Still Some Time to Move on This Must-Own Biotech

February 24, 2021 by Don Yocham

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Some market-leading biotech firms are working hard right now developing drugs derived from cannabis' many beneficial compounds.

And there's one innovative company that puts you right in the middle of the sector's market-crushing gains.

Plus, there's still some time left to get in and grab the profits….

Read more...

stocks

The 3 Best Biotech Stocks to Buy in June 2018

June 11, 2018 by Money Morning News Team

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

By 2025, the biotech industry will be worth will be $727 billion – a 120% increase over its total value in 2015.

To help you take advantage of the tremendous gains in biotech stocks, we're bringing you the three best biotech stocks to buy this month.

You see, Wall Street has put some of the best biotech stocks "on sale" due to fears over development delays, Washington's pushback against high drug prices, and a lack of consumer demand.

Stocks

The 3 Best Biotech Stocks to Buy Today

May 23, 2018 by Money Morning News Team

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Since hitting a high in late January, the iShares Nasdaq Biotechnology ETF has slumped more than 11%. But that doesn't mean investors should stop looking for the best biotech stocks to buy today.

You see, the slump in biotech stocks has little to do with their true worth.

In fact, some of the best biotech stocks are currently trading well below their fundamental value, according to their earnings and assets.

Here are the three best biotech stocks to buy now, while they're still on sale...

Biotechnology

Biotech Stocks Are Ready to Break Out, So Grab These 3 Deals Now

May 2, 2018 by Stephen Mack

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Biotech stocks have been getting hit hard in early 2018, but it's largely because of market overreactions to minor setbacks and rumors.

Based on earnings and assets, some biotech stocks are now available at remarkable discounts.

We've got three picks that are ready to break out in a big way.

Stocks

The Best Stocks to Buy Now: Take a Ride on the Road to Wealth

July 14, 2017 by Stephen Mack

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Our latest round of stocks to buy now is heavy on tech.

These stocks capitalize on legal marijuana, tailwinds in the biotech industry, a race to build a supercomputer, and the urbanization of the tech industry.

Don't miss out on these gains.

Biotechnology

Three Biotech Bargains to Buy Right Now

July 10, 2017 by Michael A. Robinson

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Back in October, I did something crazy.

That's when I told the paid-up members of my Radical Technology Profits trading service to buy a small-cap biotech stock.

Here's why that move was a bit nuts.

At the time, it looked like Hillary Clinton would soon enter in the White House and clamp down on drug prices – and so the biopharmaceutical sector was deeply out of favor.

Turns out, however, our crazy bet paid off.

Despite his campaign rhetoric, President Donald Trump has pulled back from his own fiery rhetoric about drug-price caps.

That helped pushed biotech and drug stocks into a big uptrend.

And my paid-up members made peak gains of 116% – in just over eight months.

Today, things have changed – and investing in biopharma stocks is generally seen as a smart move. However, that means a lot of these shares have been bid up, and your best move is to buy big winners at deep discounts.

But to do that, you have to know how to find those deals.

I do.

Today I'll show you how you can, too.

And I'll reveal the three best biotech bargains out there right now.

All three have triple-digit gains potential...

Biotech Investing

$30 Billion Deal Between Top Pharmaceutical Companies Is a Major Buy Signal

August 6, 2015 by Kyle Anderson

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Another possible deal between two of the world's top pharmaceutical companies was announced this week when Shire Plc. (Nasdaq: SHPG) made an unsolicited offer of $30.6 billion for Baxalta Inc. (NYSE: BXLT).

Money Morning Defense & Tech Specialist Michael A. Robinson has been following this trend since 2014. He knew the world's top pharmaceutical companies would continue their M&A binge, and he recommended an investment to play that wave.

Robinson's pick has already climbed 17.6% this year and still has plenty of room to run...

Latest News

September 15, 2023 • By Shah Gilani

We're Headed for a Second Banking Crisis - Here's What to Do

September 14, 2023 • By Tom Gentile

Tulips Are the Secret to Trading the Next 300% Rally in AI

September 14, 2023 • By Chris Johnson

Tulips Are Telling Me How To Trade the Next 300% rally in AI
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Penny Hawk Midday Momentum
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Quantum Data Profits Flashpoint Trader Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance L.A.U.N.C.H. Investor Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information